Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425944 · ClinicalTrials.gov registry record
Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
A clinical trial of Sturge-Weber Syndrome, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Active
- Registry status
- 600
- Enrollment target
- 7
- Study locations
NCT01425944 is a study of Sturge-Weber Syndrome that is active but no longer recruiting, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 600 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT01425944, a study of Sturge-Weber Syndrome, is active but no longer recruiting, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study has three aims that hope to expand the knowledge on the cause of Sturge-Weber Syndrome (SWS) and improve clinical care of Sturge-Weber Syndrome patients.
Conditions Studied
Study Locations (7)
Ohio
- Cincinnati Children's Hospital - Cincinnati
- Nationwide Children's Hospital - Columbus
Maryland
- Kennedy Krieger Institute - Baltimore
Michigan
- Wayne State University/Children's Hospital of Michigan - Detroit
New York
- New York University - New York
Pennsylvania
- Wills Eye Institute - Philadelphia
Texas
- Baylor College of Medicine/Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2010-09 |
| Est. Completion | 2027-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01425944
The ClinicalTrials.gov registry entry for NCT01425944 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sturge-Weber Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01425944 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Ohio, Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT01425944 about?
NCT01425944 is a clinical study titled "Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome". This study has three aims that hope to expand the knowledge on the cause of Sturge-Weber Syndrome (SWS) and improve clinical care of Sturge-Weber Syndrome patients.
What is the current status of trial NCT01425944?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2010-09. Estimated completion is 2027-02-09.
What conditions does trial NCT01425944 study?
This clinical trial studies the following conditions: Sturge-Weber Syndrome.
Who is sponsoring clinical trial NCT01425944?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01425944 being conducted?
This trial has 7 study locations across Maryland, Michigan, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sturge-Weber Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.